X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1273) 1273
Publication (153) 153
Newsletter (59) 59
Book Review (13) 13
Book Chapter (2) 2
Magazine Article (2) 2
Report (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (794) 794
stavudine (614) 614
pharmacology & pharmacy (504) 504
hiv infections - drug therapy (442) 442
male (350) 350
female (317) 317
stavudine - pharmacology (313) 313
infectious diseases (311) 311
anti-hiv agents - pharmacology (284) 284
hiv-1 - drug effects (268) 268
adult (265) 265
index medicus (261) 261
hiv (254) 254
anti-hiv agents - therapeutic use (252) 252
stavudine - therapeutic use (239) 239
zidovudine (238) 238
lamivudine (207) 207
virology (204) 204
reverse transcriptase inhibitors - pharmacology (195) 195
antiretroviral therapy (182) 182
drug therapy, combination (175) 175
zidovudine - pharmacology (171) 171
hiv infections - virology (167) 167
antiviral agents (158) 158
microbiology (156) 156
human-immunodeficiency-virus (155) 155
middle aged (155) 155
reverse transcriptase inhibitors - therapeutic use (153) 153
animals (152) 152
aids (146) 146
anti-hiv agents - administration & dosage (136) 136
hiv-1 - genetics (135) 135
stavudine - administration & dosage (135) 135
therapy (113) 113
anti-hiv agents - pharmacokinetics (111) 111
viral load (111) 111
didanosine (110) 110
nevirapine (110) 110
immunology (109) 109
stavudine - pharmacokinetics (106) 106
drugs (105) 105
stavudine - adverse effects (104) 104
stavudine - chemistry (103) 103
anti-hiv agents - adverse effects (102) 102
cell line (102) 102
highly active antiretroviral therapy (102) 102
mutation (102) 102
pharmacokinetics (102) 102
protease inhibitors (102) 102
stavudine - analogs & derivatives (100) 100
tenofovir (99) 99
drug therapy (98) 98
hiv infection (98) 98
lamivudine - therapeutic use (98) 98
zidovudine - therapeutic use (98) 98
pharmacology/toxicology (96) 96
cd4 lymphocyte count (92) 92
medicine & public health (91) 91
antiretroviral drugs (89) 89
reverse-transcriptase inhibitors (87) 87
biochemistry & molecular biology (85) 85
stavudine, adverse reactions (85) 85
stavudine, adverse reactions - serious (84) 84
anti-hiv agents - chemistry (81) 81
hiv-infected patients (80) 80
risk factors (79) 79
efavirenz (78) 78
antiretroviral therapy, highly active (77) 77
research (77) 77
hiv-1 (76) 76
human immunodeficiency virus--hiv (76) 76
chemistry, medicinal (75) 75
treatment outcome (74) 74
lamivudine - pharmacology (73) 73
toxicity (72) 72
antiviral agents - pharmacology (71) 71
combination therapy (70) 70
infection (69) 69
reverse-transcriptase (69) 69
drug resistance (68) 68
hiv - drug effects (68) 68
reverse transcriptase inhibitors - administration & dosage (68) 68
human immunodeficiency virus (67) 67
drug safety and pharmacovigilance (65) 65
hiv reverse transcriptase - genetics (65) 65
virus diseases (64) 64
child (62) 62
drug resistance, viral (62) 62
stavudine - metabolism (62) 62
adolescent (61) 61
nevirapine - therapeutic use (61) 61
reverse transcriptase inhibitors - adverse effects (60) 60
d4t (59) 59
didanosine - therapeutic use (59) 59
dosage and administration (59) 59
mice (59) 59
abacavir (58) 58
lamivudine - administration & dosage (58) 58
nucleosides (58) 58
research article (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1321) 1321
Russian (5) 5
French (3) 3
Spanish (3) 3
Chinese (2) 2
Japanese (2) 2
German (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 7, p. e0181357
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 10, pp. 769 - 779
Journal Article
Medicinal Research Reviews, ISSN 0198-6325, 11/2008, Volume 28, Issue 6, pp. 929 - 953
This review article, while autobiographical to some extent, describes the discovery of ten (classes of) antiviral compounds that have made (or just did not... 
HEPT | antivirals | valaciclovir | DHPA | tenofovir | stavudine | TIBO | AMD3100 | cidofovir | adefovir | BVDU | Tenofovir | Adefovir | Antivirals | Valaciclovir | Cidofovir | Stavudine | SELECTIVE-INHIBITION | CHEMISTRY, MEDICINAL | CHRONIC HEPATITIS-B | CHEMOKINE RECEPTOR CXCR4 | REVERSE-TRANSCRIPTASE | HUMAN-IMMUNODEFICIENCY-VIRUS | PLUS G-CSF | SEVERE HERPES-ZOSTER | ACYCLIC NUCLEOSIDE PHOSPHONATES | TRANSCRIPTASE INHIBITORS NNRTIS | ADENOSYLHOMOCYSTEINE HYDROLASE INHIBITORS | PHARMACOLOGY & PHARMACY | Cytosine - analogs & derivatives | Acyclovir - therapeutic use | Humans | Heterocyclic Compounds - pharmacology | Imidazoles - chemistry | Adenine - chemistry | Valine - chemistry | Virus Diseases - drug therapy | Acyclovir - chemistry | Heterocyclic Compounds - chemistry | Adenine - therapeutic use | Antiviral Agents - chemistry | Nucleosides - pharmacology | Cytosine - pharmacology | Cytosine - therapeutic use | Imidazoles - therapeutic use | Nucleosides - therapeutic use | Antiviral Agents - pharmacology | Nucleosides - chemistry | Adenine - analogs & derivatives | Benzodiazepines - pharmacology | Organophosphonates - therapeutic use | Acyclovir - analogs & derivatives | Antiviral Agents - therapeutic use | Valine - analogs & derivatives | Acyclovir - pharmacology | Adenine - pharmacology | Imidazoles - pharmacology | Cytosine - chemistry | Organophosphonates - pharmacology | Organophosphonates - chemistry | Benzodiazepines - chemistry | Valine - therapeutic use | Heterocyclic Compounds - therapeutic use | Valine - pharmacology | Benzodiazepines - therapeutic use
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2001, Volume 276, Issue 26, pp. 23616 - 23623
Mitochondrial toxicity can result hom antiviral nucleotide analog therapy used to control human immunodeficiency virus type 1 infection. We evaluated the... 
INTRACELLULAR PHOSPHORYLATION | EXONUCLEASE ACTIVITY | SUBSTRATE-SPECIFICITY | NUCLEOSIDE ANALOGS | (-)-2'-DEOXY-3'-THIACYTIDINE 3TC | BIOCHEMISTRY & MOLECULAR BIOLOGY | REVERSE-TRANSCRIPTASE | ANTI-HIV DEOXYNUCLEOTIDES | INSERTION FIDELITY | HUMAN-IMMUNODEFICIENCY-VIRUS | MITOCHONDRIAL-DNA | Anti-HIV Agents - pharmacology | DNA Polymerase gamma | Zidovudine - metabolism | Deoxyribonucleotides - pharmacology | DNA Replication - drug effects | Humans | Cytidine Triphosphate - metabolism | Reverse Transcriptase Inhibitors - pharmacology | Substrate Specificity | Zalcitabine - pharmacology | Exodeoxyribonucleases - antagonists & inhibitors | Lamivudine - analogs & derivatives | Nucleic Acid Synthesis Inhibitors | Stavudine - pharmacology | Thymine Nucleotides - metabolism | DNA - biosynthesis | Deoxyguanine Nucleotides - metabolism | Anti-HIV Agents - metabolism | Thymine Nucleotides - pharmacology | Cytidine Triphosphate - pharmacology | Deoxyguanine Nucleotides - pharmacology | Lamivudine - metabolism | Zidovudine - pharmacology | Zalcitabine - metabolism | Stavudine - metabolism | Deoxyribonucleotides - metabolism | Zidovudine - analogs & derivatives | Exodeoxyribonucleases - metabolism | Cytidine Triphosphate - analogs & derivatives | Lamivudine - pharmacology | Reverse Transcriptase Inhibitors - metabolism | DNA-Directed DNA Polymerase - metabolism | Dideoxynucleotides | Kinetics
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2013, Volume 57, Issue 1, pp. 543 - 551
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e72152
Objective: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. Design:... 
VIRAL LOAD | SUBTYPE | RESOURCE-LIMITED SETTINGS | SCALE-UP | COMMUNITY | SUB-SAHARAN AFRICA | MULTIDISCIPLINARY SCIENCES | ACCUMULATION | OUTCOMES | PREVALENCE | C-INFECTED PATIENTS | Anti-HIV Agents - pharmacology | Prevalence | Outcome Assessment (Health Care) | HIV Infections - epidemiology | Humans | Middle Aged | Male | Nevirapine - therapeutic use | Young Adult | Stavudine - pharmacology | Stavudine - therapeutic use | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Drug Therapy, Combination | Cross-Sectional Studies | HIV-1 - drug effects | HIV Infections - virology | South Africa - epidemiology | Zidovudine - pharmacology | Genotype | HIV-1 - genetics | Benzoxazines - therapeutic use | Nevirapine - pharmacology | Drug Resistance, Viral - genetics | Analysis of Variance | Adolescent | Benzoxazines - pharmacology | Drug Resistance, Viral - drug effects | HIV Infections - drug therapy | Zidovudine - therapeutic use | Lamivudine - pharmacology | Mutation | Antiviral agents | Primary health care | AIDS treatment | Analysis | Medical care | Adults | HIV (Viruses) | Anti-HIV agents | Quality management | Health care | Therapy | Nevirapine | Childrens health | Stavudine | Drug resistance | Efavirenz | Confidence intervals | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Population | Drug therapy | Failure | Public health | Antiretroviral drugs | Sequences | Clinics | Rural areas | Lamivudine | Primary care | Antiretroviral therapy | Studies | Zidovudine | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 2014, Volume 58, Issue 8, pp. 4915 - 4919
Journal Article
AIDS, ISSN 0269-9370, 11/2004, Volume 18, Issue 16, pp. 2127 - 2136
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 12/2012, Volume 19, Issue 35, pp. 5924 - 5939
Journal Article